ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $313,304 | -37.4% | 11,660 | -17.0% | 0.00% | -50.0% |
Q2 2023 | $500,666 | +36.0% | 14,040 | -3.1% | 0.00% | +100.0% |
Q1 2023 | $368,046 | -39.7% | 14,490 | -3.8% | 0.00% | -66.7% |
Q4 2022 | $610,793 | +9.1% | 15,059 | -11.0% | 0.00% | 0.0% |
Q3 2022 | $560,000 | -20.2% | 16,929 | -15.1% | 0.00% | 0.0% |
Q2 2022 | $702,000 | -24.8% | 19,934 | -1.9% | 0.00% | 0.0% |
Q1 2022 | $934,000 | -31.7% | 20,319 | -1.5% | 0.00% | -25.0% |
Q4 2021 | $1,367,000 | +5.8% | 20,619 | -0.4% | 0.00% | 0.0% |
Q3 2021 | $1,292,000 | -25.4% | 20,702 | -1.0% | 0.00% | -33.3% |
Q2 2021 | $1,732,000 | +23.1% | 20,914 | -1.4% | 0.01% | +20.0% |
Q1 2021 | $1,407,000 | -17.2% | 21,218 | -4.2% | 0.01% | -16.7% |
Q4 2020 | $1,699,000 | +69.4% | 22,140 | -4.9% | 0.01% | +50.0% |
Q3 2020 | $1,003,000 | +3.0% | 23,290 | +3.3% | 0.00% | -20.0% |
Q2 2020 | $974,000 | +43.4% | 22,540 | -4.5% | 0.01% | +25.0% |
Q1 2020 | $679,000 | -77.2% | 23,590 | -49.8% | 0.00% | -73.3% |
Q4 2019 | $2,982,000 | +174.8% | 47,013 | +22.0% | 0.02% | +150.0% |
Q3 2019 | $1,085,000 | +4.7% | 38,520 | -1.5% | 0.01% | 0.0% |
Q2 2019 | $1,036,000 | +43.1% | 39,100 | -0.9% | 0.01% | +50.0% |
Q1 2019 | $724,000 | -10.7% | 39,450 | -39.6% | 0.00% | -33.3% |
Q4 2018 | $811,000 | -37.4% | 65,325 | -3.3% | 0.01% | -25.0% |
Q3 2018 | $1,296,000 | +50.9% | 67,580 | +7.0% | 0.01% | +33.3% |
Q2 2018 | $859,000 | +28.4% | 63,170 | -32.0% | 0.01% | +20.0% |
Q1 2018 | $669,000 | – | 92,850 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |